Rockwell Medical Technologies (RMTI) 10.37 $RMTI
Trade-Ideas: Rockwell Medical (RMTI) Is Today's Strong On High Relative Volume Stock
at The Street - Thu Apr 16, 9:14AM CDT
Trade-Ideas LLC identified Rockwell Medical (RMTI) as a strong on high relative volume candidate
RMTI: 10.37 (-0.23)
Rockwell Medical Announces Triferic(TM) Clinical Data Selected for Four Poster Presentations at National Kidney Foundation Spring Clinical Meetings March 26-29, 2015 in Dallas, Texas
GlobeNewswire - Thu Mar 26, 2:54PM CDT
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that four individual abstracts for Triferic have been selected by the National Kidney Foundation (NKF) for presentation at their Spring Clinical Meetings, March 26-29, 2015 at the Gaylord Texan in Dallas, Texas. Triferic is the Company's recent FDA-approved iron-replacement drug for the treatment of iron deficiency in chronic kidney disease patients receiving hemodialysis.
RMTI: 10.37 (-0.23)
Rockwell Medical (RMTI) CEO Rob Chioini on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sun Mar 01, 7:24AM CST
RMTI: 10.37 (-0.23)
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
RESN: 3.90 (+0.06), PEGA: 22.35 (+0.13), IQNT: 19.31 (+0.94), PFMT: 3.22 (-0.04), HAWKB: 35.47 (-0.04), STAA: 9.14 (+0.02), LKQ: 25.58 (unch), VTAE: 14.05 (+0.12), BDBD: 10.14 (-0.05), HAWK: 35.67 (-0.03), RMTI: 10.37 (-0.23), PLKI: 59.22 (+2.06), ANIK: 38.35 (-0.32), TASR: 29.67 (-0.01), SNMX: 5.50 (-0.02)
Should Rockwell Medical (RMTI) Be On Your Radar Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 7:32AM CST
One company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Rockwell Medical, the stock of which company has actually seen rising estimates over the past one month.
RMTI: 10.37 (-0.23)
Rockwell Medical reports 4Q loss
Automated Insights - Thu Feb 26, 5:27PM CST
WIXOM, Mich. (AP) _ Rockwell Medical Inc. (RMTI) on Thursday reported a loss of $6.4 million in its fourth quarter.
RMTI: 10.37 (-0.23)
Rockwell Medical misses by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 3:03PM CST
RMTI: 10.37 (-0.23)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:35PM CST
HLF: 41.10 (-3.75), MNST: 141.78 (+1.42), NOG: 8.38 (-0.14), MAIN: 31.39 (+0.09), MVNR: 17.44 (-0.05), EVHC: 39.58 (+0.05), RP: 19.76 (+0.24), ENV: 54.31 (-0.22), BCEI: 24.79 (-0.22), CLNE: 8.07 (+0.42), MITT: 19.49 (+0.13), KBR: 15.85 (-0.23), NVAX: 8.58 (-0.07), PKT: 11.43 (-0.02), KND: 24.42 (+0.02), CSU: 26.68 (+0.11), OLED: 47.60 (+0.26), IM: 25.65 (+0.08), DGI: 33.16 (-0.63), AHT: 9.52 (+0.02), LYV: 25.99 (+0.01), ECOL: 49.43 (+0.31), PEGA: 22.35 (+0.13), PODD: 30.72 (+0.11), CROX: 12.97 (unch), AVD: 10.89 (-0.35), AL: 38.75 (-0.32), RBA: 25.27 (+0.25), ADSK: 62.64 (-0.11), ECPG: 41.70 (-0.08), AIRM: 47.62 (-0.31), ARUN: 24.61 (-0.03), ENOC: 11.39 (+0.12), AEGR: 25.42 (-0.52), MDRX: 12.59 (-0.15), RMTI: 10.37 (-0.23), HPTX: 45.97 (-0.11), PSIX: 64.10 (-0.19), ABTL: 15.72 (+0.35), PFMT: 3.22 (-0.04), R: 98.84 (-0.74), CERS: 4.79 (+0.20), EVC: 6.80 (+0.01), IMMR: 10.03 (-0.15), CUBE: 23.79 (+0.09), BLOX: 24.52 (+0.23), OUT: 29.21 (+0.04), OVTI: 26.62 (-0.19), MTZ: 17.88 (+0.13), APEI: 30.58 (-0.33), MENT: 24.68 (-0.40), BIO: 137.41 (+0.01), JCP: 8.41 (-0.07), PE: 16.72 (+0.02), NMBL: 24.38 (-0.28), GPS: 40.86 (-0.36), ROST: 104.38 (-0.13)
Why Earnings Season Could Be Great for Rockwell Medical (RMTI) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:42AM CST
Analysts raising estimates right before earnings is a pretty good indicator of some favorable trends underneath the surface for Rockwell Medical.
RMTI: 10.37 (-0.23)
Keryx Should Appreciate As Auryxia's Use And Suitability Grow
Zvi Bar - at Seeking Alpha - Thu Feb 19, 7:30AM CST
DVA: 83.91 (+0.50), RMTI: 10.37 (-0.23), SNY: 51.75 (-0.01), KERX: 11.41 (-0.32)
Stay Away From Financials - Cramer's Lightning Round (1/30/15)
SA Editor Mohit Manghnani - Seeking Alpha - Mon Feb 02, 4:37AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, January 30. Bullish Calls: FireEye (NASDAQ: FEYE ): " I like FireEye, I like the whole segment." Vector Group (NYSE: VGR ): " I like...
WFM: 49.63 (+1.38), HAIN: 61.33 (-0.67), FEYE: 44.03 (+0.10), SWKS: 93.39 (-2.43), ALLY: 19.95 (-0.44), GWPH: 121.00 (+0.23), AON: 97.84 (+0.43), STKL: 10.56 (-0.32), RMTI: 10.37 (-0.23), SIMO: 30.40 (-2.75), VGR: 22.60 (+0.07)
'Mad Money' Lightning Round: I'm in GW Pharmaceuticals for the Long Term
at The Street - Sat Jan 31, 5:00AM CST
Cramer likes FireEye, does not like Rockwell Medical and is staying away from Ally Financial and Aon.
WFM: 49.63 (+1.38), HAIN: 61.33 (-0.67), FEYE: 44.03 (+0.10), SWKS: 93.39 (-2.43), GWPH: 121.00 (+0.23), ALLY: 19.95 (-0.44), STKL: 10.56 (-0.32), AON: 97.84 (+0.43), RMTI: 10.37 (-0.23), SIMO: 30.40 (-2.75), VGR: 22.60 (+0.07)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jan 30, 7:14PM CST
Cramer will be watching earnings from Exxon Mobil, General Motors and Buffalo Wild Wings, among many others.
WFM: 49.63 (+1.38), SHAK: 68.53 (+5.80), FEYE: 44.03 (+0.10), SWKS: 93.39 (-2.43), CLX: 109.24 (+0.14), ALLY: 19.95 (-0.44), XOM: 86.97 (-0.57), DIS: 109.53 (+0.53), STKL: 10.56 (-0.32), AON: 97.84 (+0.43), RMTI: 10.37 (-0.23), BWLD: 180.50 (+1.84), NOV: 54.20 (-1.55), HAIN: 61.33 (-0.67), GWPH: 121.00 (+0.23), BOOT: 25.59 (+0.14), CMG: 637.50 (+1.90), GM: 35.59 (-0.33), BP: 43.46 (-0.14), GOOGL: 573.66 (+16.20), TWTR: 50.82 (-0.59), SIMO: 30.40 (-2.75), VGR: 22.60 (+0.07), APC: 92.65 (-0.81)
Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Jan 30, 3:00PM CST
BCRX: 10.35 (-0.18), ACT: 295.41 (-2.95), VRX: 210.42 (+1.03), PCYC: 256.59 (-0.51), ZSPH: 40.97 (-1.90), RMTI: 10.37 (-0.23), BCLI: 4.14 (+0.02), SIEN: 16.80 (+0.33), JNJ: 101.08 (+0.62), ECYT: 6.17 (-0.13), SNY: 51.75 (-0.01), LENS: 7.38 (-0.62), REGN: 480.09 (+0.01), SYK: 96.90 (-0.28), PFE: 35.27 (-0.09), SLXP: 172.96 (+0.15), AMGN: 167.91 (-1.26), APPY: 0.56 (+0.01), MNKD: 4.80 (-0.16), CELG: 118.71 (+2.62), ISRG: 505.92 (-6.85), GILD: 103.69 (-1.52), ANIP: 70.26 (-1.52), MRK: 57.60 (+0.09), ALXN: 180.08 (-4.50), CCXI: 7.62 (-0.27), ICPT: 283.20 (-2.22), AEZS: 0.57 (unch), ATRS: 2.72 (-0.04), NASH: 33.28 (-0.07)
Use Options For A Chance To Buy RMTI At A 37% Discount
at The Street - Thu Jan 29, 10:44AM CST
Looking back to 71 days ago, Rockwell Medical, Inc priced a 6,500,000 share secondary stock offering at $9.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
RMTI: 10.37 (-0.23)
Rockwell Medical: Triferic Approved And The Stock Is Down, Now What?
ONeil Trader - at Seeking Alpha - Wed Jan 28, 2:27PM CST
RMTI: 10.37 (-0.23)
Caterpillar and Microsoft are big market movers
AP - Tue Jan 27, 3:32PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RKT: 61.25 (+0.44), OLED: 47.60 (+0.26), SWY: 35.10 (-0.04), LSCC: 6.06 (-0.28), JJSF: 105.12 (-0.22), OCN: 7.74 (-0.15), RMTI: 10.37 (-0.23), HCA: 77.74 (+0.30), MAT: 30.20 (+1.28), SIMG: 7.30 (+0.02), AAL: 52.71 (+1.26), CAT: 84.60 (-0.19), PG: 81.00 (+0.05), MSFT: 47.87 (+4.53)
Rockwell Medical (RMTI) Stock Higher Today After FDA Approves Iron Replacement Drug
at The Street - Mon Jan 26, 9:17AM CST
Shares of Rockwell Medical (RMTI) are up after the FDA approved the company's drug Triferic, which is used for treating iron loss in chronic kidney disease patients on dialysis.
RMTI: 10.37 (-0.23)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 8:14AM CST
RKT: 61.25 (+0.44), DHI: 26.57 (+0.42), OLED: 47.60 (+0.26), OIBR: 2.05 (-0.01), BDR: 0.77 (unch), ASPS: 23.24 (+0.76), OCN: 7.74 (-0.15), STX: 58.34 (-0.41), LACO: 8.70 (unch), HWAY: 17.61 (-1.89), GTI: 4.14 (-0.02), NBG: 1.23 (+0.06), FXCM: 2.08 (-0.03), RMTI: 10.37 (-0.23), BCLI: 4.14 (+0.02), MAT: 30.20 (+1.28), MWV: 47.50 (+0.41), GNRC: 46.15 (+0.15), CTP: 3.90 (-0.12), RGP: 22.89 (+0.28), CNET: 1.64 (+0.04), HLSS: 17.19 (unch)
FDA clears Triferic
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 7:22AM CST
RMTI: 10.37 (-0.23)
Trade-Ideas: Rockwell Medical (RMTI) Is Today's Strong On High Relative Volume Stock
at The Street - Thu Apr 16, 9:14AM CDT
Trade-Ideas LLC identified Rockwell Medical (RMTI) as a strong on high relative volume candidate
RMTI: 10.37 (-0.23)
Rockwell Medical Announces Triferic(TM) Clinical Data Selected for Four Poster Presentations at National Kidney Foundation Spring Clinical Meetings March 26-29, 2015 in Dallas, Texas
GlobeNewswire - Thu Mar 26, 2:54PM CDT
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that four individual abstracts for Triferic have been selected by the National Kidney Foundation (NKF) for presentation at their Spring Clinical Meetings, March 26-29, 2015 at the Gaylord Texan in Dallas, Texas. Triferic is the Company's recent FDA-approved iron-replacement drug for the treatment of iron deficiency in chronic kidney disease patients receiving hemodialysis.
RMTI: 10.37 (-0.23)
Rockwell Medical (RMTI) CEO Rob Chioini on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sun Mar 01, 7:24AM CST
RMTI: 10.37 (-0.23)
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
RESN: 3.90 (+0.06), PEGA: 22.35 (+0.13), IQNT: 19.31 (+0.94), PFMT: 3.22 (-0.04), HAWKB: 35.47 (-0.04), STAA: 9.14 (+0.02), LKQ: 25.58 (unch), VTAE: 14.05 (+0.12), BDBD: 10.14 (-0.05), HAWK: 35.67 (-0.03), RMTI: 10.37 (-0.23), PLKI: 59.22 (+2.06), ANIK: 38.35 (-0.32), TASR: 29.67 (-0.01), SNMX: 5.50 (-0.02)
Should Rockwell Medical (RMTI) Be On Your Radar Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 7:32AM CST
One company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Rockwell Medical, the stock of which company has actually seen rising estimates over the past one month.
RMTI: 10.37 (-0.23)
Rockwell Medical reports 4Q loss
Automated Insights - Thu Feb 26, 5:27PM CST
WIXOM, Mich. (AP) _ Rockwell Medical Inc. (RMTI) on Thursday reported a loss of $6.4 million in its fourth quarter.
RMTI: 10.37 (-0.23)
Rockwell Medical misses by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 3:03PM CST
RMTI: 10.37 (-0.23)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:35PM CST
HLF: 41.10 (-3.75), MNST: 141.78 (+1.42), NOG: 8.38 (-0.14), MAIN: 31.39 (+0.09), MVNR: 17.44 (-0.05), EVHC: 39.58 (+0.05), RP: 19.76 (+0.24), ENV: 54.31 (-0.22), BCEI: 24.79 (-0.22), CLNE: 8.07 (+0.42), MITT: 19.49 (+0.13), KBR: 15.85 (-0.23), NVAX: 8.58 (-0.07), PKT: 11.43 (-0.02), KND: 24.42 (+0.02), CSU: 26.68 (+0.11), OLED: 47.60 (+0.26), IM: 25.65 (+0.08), DGI: 33.16 (-0.63), AHT: 9.52 (+0.02), LYV: 25.99 (+0.01), ECOL: 49.43 (+0.31), PEGA: 22.35 (+0.13), PODD: 30.72 (+0.11), CROX: 12.97 (unch), AVD: 10.89 (-0.35), AL: 38.75 (-0.32), RBA: 25.27 (+0.25), ADSK: 62.64 (-0.11), ECPG: 41.70 (-0.08), AIRM: 47.62 (-0.31), ARUN: 24.61 (-0.03), ENOC: 11.39 (+0.12), AEGR: 25.42 (-0.52), MDRX: 12.59 (-0.15), RMTI: 10.37 (-0.23), HPTX: 45.97 (-0.11), PSIX: 64.10 (-0.19), ABTL: 15.72 (+0.35), PFMT: 3.22 (-0.04), R: 98.84 (-0.74), CERS: 4.79 (+0.20), EVC: 6.80 (+0.01), IMMR: 10.03 (-0.15), CUBE: 23.79 (+0.09), BLOX: 24.52 (+0.23), OUT: 29.21 (+0.04), OVTI: 26.62 (-0.19), MTZ: 17.88 (+0.13), APEI: 30.58 (-0.33), MENT: 24.68 (-0.40), BIO: 137.41 (+0.01), JCP: 8.41 (-0.07), PE: 16.72 (+0.02), NMBL: 24.38 (-0.28), GPS: 40.86 (-0.36), ROST: 104.38 (-0.13)
Why Earnings Season Could Be Great for Rockwell Medical (RMTI) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:42AM CST
Analysts raising estimates right before earnings is a pretty good indicator of some favorable trends underneath the surface for Rockwell Medical.
RMTI: 10.37 (-0.23)
Keryx Should Appreciate As Auryxia's Use And Suitability Grow
Zvi Bar - at Seeking Alpha - Thu Feb 19, 7:30AM CST
DVA: 83.91 (+0.50), RMTI: 10.37 (-0.23), SNY: 51.75 (-0.01), KERX: 11.41 (-0.32)
Stay Away From Financials - Cramer's Lightning Round (1/30/15)
SA Editor Mohit Manghnani - Seeking Alpha - Mon Feb 02, 4:37AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, January 30. Bullish Calls: FireEye (NASDAQ: FEYE ): " I like FireEye, I like the whole segment." Vector Group (NYSE: VGR ): " I like...
WFM: 49.63 (+1.38), HAIN: 61.33 (-0.67), FEYE: 44.03 (+0.10), SWKS: 93.39 (-2.43), ALLY: 19.95 (-0.44), GWPH: 121.00 (+0.23), AON: 97.84 (+0.43), STKL: 10.56 (-0.32), RMTI: 10.37 (-0.23), SIMO: 30.40 (-2.75), VGR: 22.60 (+0.07)
'Mad Money' Lightning Round: I'm in GW Pharmaceuticals for the Long Term
at The Street - Sat Jan 31, 5:00AM CST
Cramer likes FireEye, does not like Rockwell Medical and is staying away from Ally Financial and Aon.
WFM: 49.63 (+1.38), HAIN: 61.33 (-0.67), FEYE: 44.03 (+0.10), SWKS: 93.39 (-2.43), GWPH: 121.00 (+0.23), ALLY: 19.95 (-0.44), STKL: 10.56 (-0.32), AON: 97.84 (+0.43), RMTI: 10.37 (-0.23), SIMO: 30.40 (-2.75), VGR: 22.60 (+0.07)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jan 30, 7:14PM CST
Cramer will be watching earnings from Exxon Mobil, General Motors and Buffalo Wild Wings, among many others.
WFM: 49.63 (+1.38), SHAK: 68.53 (+5.80), FEYE: 44.03 (+0.10), SWKS: 93.39 (-2.43), CLX: 109.24 (+0.14), ALLY: 19.95 (-0.44), XOM: 86.97 (-0.57), DIS: 109.53 (+0.53), STKL: 10.56 (-0.32), AON: 97.84 (+0.43), RMTI: 10.37 (-0.23), BWLD: 180.50 (+1.84), NOV: 54.20 (-1.55), HAIN: 61.33 (-0.67), GWPH: 121.00 (+0.23), BOOT: 25.59 (+0.14), CMG: 637.50 (+1.90), GM: 35.59 (-0.33), BP: 43.46 (-0.14), GOOGL: 573.66 (+16.20), TWTR: 50.82 (-0.59), SIMO: 30.40 (-2.75), VGR: 22.60 (+0.07), APC: 92.65 (-0.81)
Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Jan 30, 3:00PM CST
BCRX: 10.35 (-0.18), ACT: 295.41 (-2.95), VRX: 210.42 (+1.03), PCYC: 256.59 (-0.51), ZSPH: 40.97 (-1.90), RMTI: 10.37 (-0.23), BCLI: 4.14 (+0.02), SIEN: 16.80 (+0.33), JNJ: 101.08 (+0.62), ECYT: 6.17 (-0.13), SNY: 51.75 (-0.01), LENS: 7.38 (-0.62), REGN: 480.09 (+0.01), SYK: 96.90 (-0.28), PFE: 35.27 (-0.09), SLXP: 172.96 (+0.15), AMGN: 167.91 (-1.26), APPY: 0.56 (+0.01), MNKD: 4.80 (-0.16), CELG: 118.71 (+2.62), ISRG: 505.92 (-6.85), GILD: 103.69 (-1.52), ANIP: 70.26 (-1.52), MRK: 57.60 (+0.09), ALXN: 180.08 (-4.50), CCXI: 7.62 (-0.27), ICPT: 283.20 (-2.22), AEZS: 0.57 (unch), ATRS: 2.72 (-0.04), NASH: 33.28 (-0.07)
Use Options For A Chance To Buy RMTI At A 37% Discount
at The Street - Thu Jan 29, 10:44AM CST
Looking back to 71 days ago, Rockwell Medical, Inc priced a 6,500,000 share secondary stock offering at $9.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
RMTI: 10.37 (-0.23)
Rockwell Medical: Triferic Approved And The Stock Is Down, Now What?
ONeil Trader - at Seeking Alpha - Wed Jan 28, 2:27PM CST
RMTI: 10.37 (-0.23)
Caterpillar and Microsoft are big market movers
AP - Tue Jan 27, 3:32PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RKT: 61.25 (+0.44), OLED: 47.60 (+0.26), SWY: 35.10 (-0.04), LSCC: 6.06 (-0.28), JJSF: 105.12 (-0.22), OCN: 7.74 (-0.15), RMTI: 10.37 (-0.23), HCA: 77.74 (+0.30), MAT: 30.20 (+1.28), SIMG: 7.30 (+0.02), AAL: 52.71 (+1.26), CAT: 84.60 (-0.19), PG: 81.00 (+0.05), MSFT: 47.87 (+4.53)
Rockwell Medical (RMTI) Stock Higher Today After FDA Approves Iron Replacement Drug
at The Street - Mon Jan 26, 9:17AM CST
Shares of Rockwell Medical (RMTI) are up after the FDA approved the company's drug Triferic, which is used for treating iron loss in chronic kidney disease patients on dialysis.
RMTI: 10.37 (-0.23)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 8:14AM CST
RKT: 61.25 (+0.44), DHI: 26.57 (+0.42), OLED: 47.60 (+0.26), OIBR: 2.05 (-0.01), BDR: 0.77 (unch), ASPS: 23.24 (+0.76), OCN: 7.74 (-0.15), STX: 58.34 (-0.41), LACO: 8.70 (unch), HWAY: 17.61 (-1.89), GTI: 4.14 (-0.02), NBG: 1.23 (+0.06), FXCM: 2.08 (-0.03), RMTI: 10.37 (-0.23), BCLI: 4.14 (+0.02), MAT: 30.20 (+1.28), MWV: 47.50 (+0.41), GNRC: 46.15 (+0.15), CTP: 3.90 (-0.12), RGP: 22.89 (+0.28), CNET: 1.64 (+0.04), HLSS: 17.19 (unch)
FDA clears Triferic
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 7:22AM CST
RMTI: 10.37 (-0.23)
